UKRAINE suspended the explanation of the dosage of the drug with INN "Insulin glargine" in public procurement
On November 30, the Agency held a joint meeting with the Ministry of health, the Ministry of industry and trade, the Ministry of Finance, drug manufacturers and other specialists. Based on its results, a working group was created to clarify the clinical recommendations and other standards for the use of the drug with INN "Insulin glargine".
As a result, there should be an algorithm for translating and prescribing the drug "Insulin glargine" in dosages of 100 U/ml and 300 U/ml, taking into account international and Russian practice. Until then, the FAS explanation on specifying the dosage of the drug with INN "Insulin glargine" in the documentation on public procurement has been suspended.
Document: an Informational message, the FAS Russia from 03.12.2020